I just found that example. I’m no expert obviously, but as Joe said they budgeted it out as costing $8.5 to develop, BARDA may eventually pay if lucky, but first you need that to develop. They don’t currently have funding. We also know from the 10K that Joe hasn’t taken any salary or anything. We also know from notes and comments in their K that he put up hundreds of thousands plus personally secured notes or whatever, so obviously their being careful in spending. They chose the vaccine. And we see how much work goes in to developing, getting agreements on multiple aspects, plus audits and legal and expensive application fees to Barda. SEC is hurting us taking so long on the S1, because they need access to capital to move forward on plans.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links